The University of Queensland
UQ Researchers
UQ Home
Contacts
Study
Maps
News
Events
Library
my.UQ
Search Entry
UQ Researchers
Experts for media
My Shortlist
FAQs
Feedback
Update Profile
UQ Researchers
Experts for media
My Shortlist
FAQs
Support & Feedback
Update Profile
Find Researchers
Find Researchers
Find Expert
OR
Browse By
Fields of Research
Organisational Units
Journal Classifications
ALLGNHL32 Study - An ALLG Phase II study of pembrolizumab checkpoint blockade following chemoimmunotherapy for primary central nervous system lymphoma (2021–2024)
Grant type:
Australasian Leukaemia & Lymphoma Group
Researchers:
Associate Professor Colm Keane
Principal Research Fellow
Frazer Institute
Faculty of Medicine
Funded by:
Australasian Leukaemia & Lymphoma Group